1. J. Gong, R. Yang, M. Zhou, et al. Improved intravenous lentiviral gene therapy based on endothelial‑specific promoter‑driven factor VIII expression for hemophilia A [J]. Molecular Medicine, 2023, 29(1): 74.

2. J. Gong, Y. Liu, T. Chung, et al. Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model [J]. Gene Therapy, 2023, 30(1-2): 18-30.

3. J. Gong, H. Wang, L. Chang. Molecular therapeutics of hemophilia A and B [J]. Expert Review of Hematology, 2022, 15(5): 431-441.

4. J. Gong, T. Chung, J. Zheng, et al. Transduction of Modified Factor VIII Gene Improves Lentiviral Gene Therapy Efficacy for Hemophilia A [J]. Journal of Biological Chemistry, 2021, 297(6): 101397.

5. Q. Wang, J. Wang, Z. Ling, Z. Cui, J. Gong, et al. Phase I clinical trial of intracerebral injection of lentiviral-ABCD1 for the treatment of cerebral adrenoleukodystrophy [J]. Science Bulletin, 2024,69(16): 2569-2603.

6. C. Chang, Y. Liu, C. Jiao, H. Liu, J. Gong, et al. A glimpse into the diverse cellular immunity against SARS-CoV-2 [J]. Vaccines, 2021, 9(8).

7. 宫洁, 陈琴, 罗俊等. 乳腺CEUS预测模型诊断乳腺恶性病灶的观察者间一致性:多中心研究. 中国医学影像技术, 2018, 34(6): 874-878.